Emit II Plus Oxycodone Assay

Enabling early detection of pain prescription abuse

The Emit II Plus Oxycodone assay offers 100 ng/mL and 300 ng/mL cutoffs and no cross-reactivity to structurally related compounds such as buprenorphine and hydrocodone.

• Achieve high specificity for oxycodone and oxymorphone to provide confidence for accurate results while meeting the SAMHSA requirements for oxycodone screening
• Reduce false results with an assay that has 98% agreement to LC-MS/MS for positive samples and 100% agreement for negatives.¹
• Consolidate opioid testing with other Siemens Healthineers assays, enabling providers to screen patients on one trusted system